Rockwell Medical Inc.

(RMTI) Trade

By |

Profile

Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The company's drug products are Triferic and Calcitriol. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. It replaces the ongoing iron loss that occurs to patients during every hemodialysis treatment, via dialysate. Calcitriol is a generic drug for treating secondary hyperparathyroidism in dialysis patients. The company operates in one segment of hemodialysis market which involves the manufacture, sale, and distribution of hemodialysis products.

Contact Information

Website: www.rockwellmed.com
Email: invest@rockwellmed.com
Main Phone: +1 248 960-9009
Address: 30142 Wixom Road
State: MI
City / Town: Wixom
Country: USA
Postal Code: 48393

Issuer Information

Exchange: NSD
CEO: Stuart Paul
Employees: 300
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The company's drug products are Triferic and Calcitriol. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. It replaces the ongoing iron loss that occurs to patients during every hemodialysis treatment, via dialysate. Calcitriol is a generic drug for treating secondary hyperparathyroidism in dialysis patients. The company operates in one segment of hemodialysis market which involves the manufacture, sale, and distribution of hemodialysis products.

Contact Information

Website: www.rockwellmed.com
Email: invest@rockwellmed.com
Main Phone: +1 248 960-9009
Address: 30142 Wixom Road
State: MI
City / Town: Wixom
Country: USA
Postal Code: 48393

Issuer Information

Exchange: NSD
CEO: Stuart Paul
Employees: 300
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 6.36 $ -0.06 (-0.93%)
Last Price 6.36 Change $ -0.06 Change % -0.93 Tick N/A
Bid 6.11 Bid Size 300.00 Ask N/A Ask Size 0.00
Open 6.42 High 6.88 Low 6.28 Prev Close 6.42
Last Trade Volume 612,122 52 Wk Hi 6.88 52 Wk Low 2.19
Market Cap 363.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 57,098,327.00 EPS (TTM) -0.62 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 20
Number of Buys 0 10
Number of Sells 0 10
Net Activity 0 -304794
Last 10 Buys Shares
David S. Richmond 1,000
David S. Richmond 1,000
David S. Richmond 1,000
David S. Richmond 1,000
David S. Richmond 1,000
Robert L. Chioini 1,000
Ajay Gupta 1,000
Ajay Gupta 1,000
Robert L. Chioini 1,000
Robert L. Chioini 1,000
Last 10 Sell Shares
David S. Richmond 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 6.5 6.5 6.5 6.5
Low Target Price Estimate 2 2 2 2
Mean Target Price Estimate 4.25 4.25 4.25 4.25
Standard Deviation 3.18 3.18 3.18 3.18
Date of Most Recent Estimate 03/16/18 03/16/18 03/16/18 03/16/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.65 2.65 2.65 2.65